Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
clarithromycin | potassium voltage-gated channel subfamily h member 2 | small molecule | NA | drugbank | Endocarditis[MeSHID:D004696] Bacteremia[MeSHID:D016470] Tonsillitis[MeSHID:D014069] Skin Diseases Infectious[MeSHID:D012874] Hemolysis (disorder)[MeSHID:D006461] Pharyngitis[MeSHID:D010612] Infection[MeSHID:D007239] Encephalitis[MeSHID:D004660] Legionnaires' Disease[MeSHID:D007877] Pneumonia[MeSHID:D011014] Respiratory Tract Infections[MeSHID:D012141] Duodenal Ulcer[MeSHID:D004381] Cryptosporidiosis[MeSHID:D003457] Maxillary Sinusitis[MeSHID:D015523] Pertussis[MeSHID:D014917] Bartonella Infections[MeSHID:D001474] Otitis Media[MeSHID:D010033] HIV Infections[MeSHID:D015658] Immediate hypersensitivity[MeSHID:D006969] Communicable Diseases[MeSHID:D003141] Lyme Disease[MeSHID:D008193] Bronchitis Chronic[MeSHID:D029481] Bacterial Infections[MeSHID:D001424] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
clarithromycin | potassium voltage-gated channel subfamily h member 2 | small molecule | NA | drugbank | Endocarditis[MeSHID:D004696] Bacteremia[MeSHID:D016470] Tonsillitis[MeSHID:D014069] Skin Diseases Infectious[MeSHID:D012874] Hemolysis (disorder)[MeSHID:D006461] Pharyngitis[MeSHID:D010612] Infection[MeSHID:D007239] Encephalitis[MeSHID:D004660] Legionnaires' Disease[MeSHID:D007877] Pneumonia[MeSHID:D011014] Respiratory Tract Infections[MeSHID:D012141] Duodenal Ulcer[MeSHID:D004381] Cryptosporidiosis[MeSHID:D003457] Maxillary Sinusitis[MeSHID:D015523] Pertussis[MeSHID:D014917] Bartonella Infections[MeSHID:D001474] Otitis Media[MeSHID:D010033] HIV Infections[MeSHID:D015658] Immediate hypersensitivity[MeSHID:D006969] Communicable Diseases[MeSHID:D003141] Lyme Disease[MeSHID:D008193] Bronchitis Chronic[MeSHID:D029481] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
clarithromycin | solute carrier organic anion transporter family member 1b1 | small molecule | NA | drugbank | Endocarditis[MeSHID:D004696] Bacteremia[MeSHID:D016470] Tonsillitis[MeSHID:D014069] Skin Diseases Infectious[MeSHID:D012874] Hemolysis (disorder)[MeSHID:D006461] Pharyngitis[MeSHID:D010612] Infection[MeSHID:D007239] Encephalitis[MeSHID:D004660] Legionnaires' Disease[MeSHID:D007877] Pneumonia[MeSHID:D011014] Respiratory Tract Infections[MeSHID:D012141] Duodenal Ulcer[MeSHID:D004381] Cryptosporidiosis[MeSHID:D003457] Maxillary Sinusitis[MeSHID:D015523] Pertussis[MeSHID:D014917] Bartonella Infections[MeSHID:D001474] Otitis Media[MeSHID:D010033] HIV Infections[MeSHID:D015658] Immediate hypersensitivity[MeSHID:D006969] Communicable Diseases[MeSHID:D003141] Lyme Disease[MeSHID:D008193] Bronchitis Chronic[MeSHID:D029481] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
clarithromycin | solute carrier organic anion transporter family member 1b1 | small molecule | NA | drugbank | Endocarditis[MeSHID:D004696] Bacteremia[MeSHID:D016470] Tonsillitis[MeSHID:D014069] Skin Diseases Infectious[MeSHID:D012874] Hemolysis (disorder)[MeSHID:D006461] Pharyngitis[MeSHID:D010612] Infection[MeSHID:D007239] Encephalitis[MeSHID:D004660] Legionnaires' Disease[MeSHID:D007877] Pneumonia[MeSHID:D011014] Respiratory Tract Infections[MeSHID:D012141] Duodenal Ulcer[MeSHID:D004381] Cryptosporidiosis[MeSHID:D003457] Maxillary Sinusitis[MeSHID:D015523] Pertussis[MeSHID:D014917] Bartonella Infections[MeSHID:D001474] Otitis Media[MeSHID:D010033] HIV Infections[MeSHID:D015658] Immediate hypersensitivity[MeSHID:D006969] Communicable Diseases[MeSHID:D003141] Lyme Disease[MeSHID:D008193] Bronchitis Chronic[MeSHID:D029481] Bacterial Infections[MeSHID:D001424] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
clarithromycin | solute carrier organic anion transporter family member 1b3 | small molecule | NA | drugbank | Endocarditis[MeSHID:D004696] Bacteremia[MeSHID:D016470] Tonsillitis[MeSHID:D014069] Skin Diseases Infectious[MeSHID:D012874] Hemolysis (disorder)[MeSHID:D006461] Pharyngitis[MeSHID:D010612] Infection[MeSHID:D007239] Encephalitis[MeSHID:D004660] Legionnaires' Disease[MeSHID:D007877] Pneumonia[MeSHID:D011014] Respiratory Tract Infections[MeSHID:D012141] Duodenal Ulcer[MeSHID:D004381] Cryptosporidiosis[MeSHID:D003457] Maxillary Sinusitis[MeSHID:D015523] Pertussis[MeSHID:D014917] Bartonella Infections[MeSHID:D001474] Otitis Media[MeSHID:D010033] HIV Infections[MeSHID:D015658] Immediate hypersensitivity[MeSHID:D006969] Communicable Diseases[MeSHID:D003141] Lyme Disease[MeSHID:D008193] Bronchitis Chronic[MeSHID:D029481] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
clarithromycin | solute carrier organic anion transporter family member 1b3 | small molecule | NA | drugbank | Endocarditis[MeSHID:D004696] Bacteremia[MeSHID:D016470] Tonsillitis[MeSHID:D014069] Skin Diseases Infectious[MeSHID:D012874] Hemolysis (disorder)[MeSHID:D006461] Pharyngitis[MeSHID:D010612] Infection[MeSHID:D007239] Encephalitis[MeSHID:D004660] Legionnaires' Disease[MeSHID:D007877] Pneumonia[MeSHID:D011014] Respiratory Tract Infections[MeSHID:D012141] Duodenal Ulcer[MeSHID:D004381] Cryptosporidiosis[MeSHID:D003457] Maxillary Sinusitis[MeSHID:D015523] Pertussis[MeSHID:D014917] Bartonella Infections[MeSHID:D001474] Otitis Media[MeSHID:D010033] HIV Infections[MeSHID:D015658] Immediate hypersensitivity[MeSHID:D006969] Communicable Diseases[MeSHID:D003141] Lyme Disease[MeSHID:D008193] Bronchitis Chronic[MeSHID:D029481] Bacterial Infections[MeSHID:D001424] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
click here to return to the previous page |